GI Medicine Trials

  • 14/07/2022

    JUNIPER

    AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE PREVIOUSLY ENROLLED IN THE ETROLIZUMAB PHASE III PROTOCOL GA29144

    View Trial
  • 31/05/2018

    ENDCaP-C Test Accuracy Study

    Enhanced Neoplasia Detection and Cancer Prevention in Chronic Colitis (ENDCaPC) A Multicentre test accuracy study

    View Trial
  • 30/09/2020

    MONOFER STUDY

    A randomized double-blinded comparative trial comparing the incidence of hypophosphatemia in relation to repeated treatment courses of iron isomaltoside and ferric carboxymalt-ose in subjects with iron deficiency anaemia due to inflamma-tory bowel disease

    View Trial
  • 31/12/2020

    A Phase 2 Multicenter Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy and Safety of ST-0529 in Subjects with Moderately to Severely Active Ulcerative Colitis.

    View Trial
  • 30/03/2015

    Use of human bowel organ cultures to assess the therapeutic potential of targeting vascular adhesion protein-1 and other adhesion molecules in inflammatory bowel disease

    View Trial
  • 29/05/2017

    Gut microbiota profiling for diseased states

    View Trial
  • 26/05/2017

    Diffusion of Non- Commercial Innovation in Hospitals

    View Trial
  • 01/12/2020

    A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease

    View Trial
  • 31/03/2020

    Combined Phase 3 Double-blind Randomized Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease

    View Trial
  • 01/03/2019

    Physiological and psychological responses to stress in individuals with inflammatory bowel disease

    View Trial